遺伝子編集市場:製品・サービス別(試薬、消耗品、システム、ソフトウェア)、技術別(CRISPR、TALEN、ZFN、アンチセンス)、用途別(細胞株工学、遺伝子工学、創薬)、エンドユーザー別(製薬、バイオテクノロジー) 2028年までの世界予測Gene Editing Market by Product & Service (Reagents, Consumables, Systems, Software), Technology (CRISPR, TALEN, ZFN, Antisense), Application (Cell Line Engineering, Genetic Engineering, Drug Discovery), End User (Pharma, Biotech) Global Forecast to 2028 遺伝子編集市場は、CAGR15.0%で2023年の53億米ドルから2028年には106億米ドルに成長すると予測されている。政府資金の増加とゲノミクス・プロジェクト数の増加が、市場にとってインパクトの大きい推進要因として... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー遺伝子編集市場は、CAGR15.0%で2023年の53億米ドルから2028年には106億米ドルに成長すると予測されている。政府資金の増加とゲノミクス・プロジェクト数の増加が、市場にとってインパクトの大きい推進要因として浮上している。2022年3月、米国国立衛生研究所(NIH)は遺伝子編集研究への資金提供を拡大し、追加プロジェクトに8900万米ドルを割り当てた。同様に、欧州連合(EU)はHorizon 2020プログラムを立ち上げ、ゲノム研究と遺伝子編集プロジェクトを促進するために多額の財源を提供している。さらに、中国、日本、韓国を含むいくつかの国は、遺伝子編集技術の進歩を推進するために、国家ゲノムプログラムを設立し、専用の資金を提供している。"予測期間中、遺伝子編集サービスが最も高い成長を目撃する" 製品・サービスに基づいて、遺伝子編集市場は試薬・消耗品、ソフトウェア・システム、サービスに区分される。遺伝子編集サービス市場には、シーケンスサービス、データ解析、バイオインフォマティクスサービス、およびインフォマティクス、クリーンアップ、遺伝子発現、DNA合成サービスなどのその他のサービスが含まれる。さらに、サービスプロバイダーはカスタマイズされたシーケンスサービスも提供している。生物医学アプリケーションにおけるシーケンスサービスの導入は、ゲノムシーケンスの需要を高め、遺伝子編集市場を後押しすると予想される。 "製薬・バイオテクノロジー企業が2022年の世界遺伝子編集市場で最大シェアを占める" エンドユーザーに基づき、遺伝子編集市場は製薬&バイオテクノロジー企業、学術&研究機関、その他のエンドユーザーに区分される。その他のエンドユーザーには、診断会社、CRO、CDMOが含まれる。ファーマコゲノミクスなどの製薬アプリケーションにおける遺伝子編集の高い需要が、予測期間を通じてこのセグメントの優位性に寄与している。バイオマーカーの重要性の高まりは、医薬品開発におけるバイオマーカーの様々な応用に起因して、このセグメントにおけるゲノムシステムおよびサービスの利用を促進すると予想される。これに伴い、バイオテクノロジー企業も新しい治療薬を発見・開発するためにゲノムデータベースを構築している。 「アジア太平洋地域は予測期間中に最も高いCAGRを記録すると推定されている。 遺伝子編集市場は、北米、欧州、アジア太平洋(APAC)、中南米、中東・アフリカ(MEA)に区分される。アジア太平洋地域は、研究への投資の増加や、生物の細胞や組織の遺伝子工学のための遺伝子合成の用途が増加していることから、遺伝子編集の市場が最も急成長すると予想される。がんは日本における主要な死因のひとつとなっており、政府はその有病率と死亡率を減少させるためにさまざまな取り組みを行っている。例えば、医療研究開発機構は、日本再生医療プロジェクト、日本ゲノム医療プロジェクト、日本がん研究プロジェクトなど、多くの研究プロジェクトを実施している。また、日本市場では、技術的に先進的な製品やサービスを導入・提供しようとする地元組織と大手グローバル企業との間で、さまざまな協力や提携が行われている。 供給側の一次インタビューの内訳、企業タイプ別、呼称別、地域別: - 回答者別供給側(70%)、需要側(30) - 役職別Cレベル(55%)、ディレクターレベル(20%)、その他(25%) - 地域別北米(50%)、欧州(20%)、アジア太平洋地域(20%)、その他地域(10%) レポート掲載企業一覧 - Merck KGaA (ドイツ) - サーモフィッシャーサイエンティフィック(米国) - ジェンスクリプト(中国) - アジレント・テクノロジー(米国) - パーキンエルマー(米国) - ロンザ(スイス) - テカンライフサイエンス(スイス) - サンガモ・セラピューティクス(米国) - エディタス・メディシン(米) - CRISPR Therapeutics AG (スイス) - プレシジョン・バイオサイエンシズ(米国) - Cellectis S.A.(フランス) - インテリア・セラピューティクス(米) - ブルーバード・バイオ(米) - リジェネロン・ファーマシューティカルズ(米) - AMSBIO(イギリス) - クリエイティブ・バイオジーン(米) - シンセゴ・コーポレーション(米) - ビーム・セラピューティクス(米) - カリブー・バイオサイエンシズ(米) - オリジーン・テクノロジーズ(米) - ニューイングランドバイオラボ(米) - インスクリプタ(米) - マンモス・バイオサイエンシズ(米) 調査範囲 この調査レポートは、遺伝子編集市場を製品&サービス、技術、用途、エンドユーザー、地域に基づいて調査しています。また、市場成長に影響を与える要因(促進要因、阻害要因、機会、課題など)を分析しています。利害関係者向けに市場の機会と課題を評価し、市場リーダー向けに競争状況の詳細を提供しています。また、マイクロ市場についても、その成長動向、展望、遺伝子編集市場全体への貢献に関して調査しています。主要5地域に関して市場セグメントの収益を予測しています。 レポートを購入する理由 本レポートは、以下のポイントに関する洞察を提供する: - 市場への浸透:市場上位25社が提供する遺伝子編集に関する包括的な情報。遺伝子編集市場を製品・サービス、技術、用途、エンドユーザー、地域別に分析しています。 - 市場開発:有利な新興市場に関する包括的情報。主要地域にわたる様々な製品/サービス/技術の市場を分析しています。 - 市場の多様化:遺伝子編集市場における未開拓の地域、最近の開発、投資に関する網羅的な情報。 - 競合評価:遺伝子編集市場における主要企業の市場シェアと戦略を詳細に評価 目次1 INTRODUCTION 301.1 STUDY OBJECTIVES 30 1.2 MARKET DEFINITION 30 1.2.1 INCLUSIONS & EXCLUSIONS 30 1.3 MARKET SCOPE 31 1.3.1 MARKETS COVERED 31 1.4 YEARS CONSIDERED 31 1.5 CURRENCY CONSIDERED 32 1.6 LIMITATIONS 32 1.7 STAKEHOLDERS 32 1.8 SUMMARY OF CHANGES 33 2 RESEARCH METHODOLOGY 34 2.1 RESEARCH DATA 34 FIGURE 1 RESEARCH DESIGN 34 2.1.1 SECONDARY DATA 35 2.1.2 PRIMARY DATA 35 FIGURE 2 BREAKDOWN OF PRIMARIES: GENE EDITING MARKET 36 2.2 MARKET ESTIMATION METHODOLOGY 37 FIGURE 3 GENE EDITING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022 37 FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022 38 2.2.1 INSIGHTS FROM PRIMARY EXPERTS 39 FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 39 2.3 MARKET GROWTH RATE PROJECTIONS 40 FIGURE 6 GENE EDITING MARKET (SUPPLY-SIDE): CAGR PROJECTIONS 41 FIGURE 7 GENE EDITING MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS 41 2.4 DATA TRIANGULATION 42 FIGURE 8 DATA TRIANGULATION METHODOLOGY 42 2.5 RESEARCH ASSUMPTIONS 43 2.6 RISK ANALYSIS 43 2.7 RECESSION IMPACT ANALYSIS 43 TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 44 TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 44 TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 44 3 EXECUTIVE SUMMARY 45 FIGURE 9 GENE EDITING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 45 FIGURE 10 GENE EDITING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 46 FIGURE 11 GENE EDITING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 46 FIGURE 12 GENE EDITING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 47 FIGURE 13 GEOGRAPHICAL SNAPSHOT: GENE EDITING MARKET, 2022 48 4 PREMIUM INSIGHTS 49 4.1 GENE EDITING MARKET OVERVIEW 49 FIGURE 14 GROWING INVESTMENTS IN GENOMICS RESEARCH TO DRIVE MARKET GROWTH 49 4.2 NORTH AMERICA: GENE EDITING MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022) 50 FIGURE 15 REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 50 4.3 NORTH AMERICA GENE EDITING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 50 FIGURE 16 CELL LINE ENGINEERING TO DOMINATE NORTH AMERICAN MARKET 50 5 MARKET OVERVIEW 51 5.1 INTRODUCTION 51 5.2 MARKET DYNAMICS 51 FIGURE 17 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51 TABLE 4 GENOME EDITING MARKET: IMPACT ANALYSIS 52 5.2.1 DRIVERS 52 5.2.1.1 Rising government funding and number of genomics projects 52 5.2.1.2 Growing applications of genomics 53 5.2.1.3 Introduction of CRISPR-Cas9 54 5.2.2 RESTRAINTS 54 5.2.2.1 Off-target effects of CRISPR technology 54 5.2.3 OPPORTUNITIES 55 5.2.3.1 Extensive use of genome editing in personalized medicine 55 5.2.3.2 Expanding pipeline for gene therapy 55 5.2.4 CHALLENGES 56 5.2.4.1 High equipment costs 56 5.3 TECHNOLOGY ANALYSIS 56 5.4 SUPPLY AND VALUE CHAIN ANALYSIS 58 5.4.1 GENE EDITING MARKET: SUPPLY CHAIN ANALYSIS 58 FIGURE 18 GENE EDITING MARKET: SUPPLY CHAIN ANALYSIS 58 5.4.2 VALUE CHAIN ANALYSIS 59 FIGURE 19 GENE EDITING MARKET: VALUE CHAIN ANALYSIS 59 5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 60 FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 60 5.6 PRICING ANALYSIS 61 TABLE 5 AVERAGE SELLING PRICES, BY PRODUCT (KEY PLAYER OFFERINGS) 61 5.7 REGULATORY ANALYSIS 62 5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62 TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62 TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63 TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64 TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65 TABLE 10 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66 5.8 ECOSYSTEM ANALYSIS 66 FIGURE 21 GENE EDITING MARKET: ECOSYSTEM ANALYSIS 66 5.9 PORTER’S FIVE FORCES ANALYSIS 67 TABLE 11 GENE EDITING MARKET: PORTER’S FIVE FORCES ANALYSIS 67 5.9.1 THREAT OF NEW ENTRANTS 67 5.9.2 THREAT OF SUBSTITUTES 67 5.9.3 BARGAINING POWER OF BUYERS 67 5.9.4 BARGAINING POWER OF SUPPLIERS 68 5.9.5 INTENSITY OF COMPETITIVE RIVALRY 68 5.10 KEY CONFERENCES AND EVENTS IN 2023 68 TABLE 12 GENE EDITING MARKET: CONFERENCES AND EVENTS (2023) 68 5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 69 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 69 FIGURE 22 GENE EDITING MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 69 5.11.2 GENE EDITING MARKET: BUYING CRITERIA 69 FIGURE 23 KEY BUYING CRITERIA FOR GENE EDITING 69 5.12 PATENT ANALYSIS 70 FIGURE 24 PATENTS GRANTED, JANUARY 2011–JUNE 2023 70 FIGURE 25 TOP PATENT APPLICANTS, JANUARY 2011–JUNE 2023 70 6 GENE EDITING MARKET, BY PRODUCT & SERVICE 71 6.1 INTRODUCTION 72 TABLE 13 GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 72 6.2 REAGENTS & CONSUMABLES 72 6.2.1 REAGENTS & CONSUMABLES TO HOLD LARGEST MARKET SHARE 72 TABLE 14 GENE EDITING REAGENTS & CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 73 TABLE 15 NORTH AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 73 TABLE 16 EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 73 TABLE 17 ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 74 TABLE 18 LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 74 6.3 SOFTWARE & SYSTEMS 74 6.3.1 INCREASING APPLICATIONS OF GENOME EDITING/SEQUENCING TO BOOST DEMAND FOR SYSTEMS AND SOFTWARE 74 TABLE 19 GENE EDITING SOFTWARE & SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 75 TABLE 20 NORTH AMERICA: GENE EDITING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 75 TABLE 21 EUROPE: GENE EDITING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76 TABLE 22 ASIA PACIFIC: GENE EDITING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76 TABLE 23 LATIN AMERICA: GENE EDITING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76 6.4 SERVICES 77 6.4.1 RISING DEMAND FOR SERVICES TO SUPPORT GROWTH 77 TABLE 24 GENE EDITING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 77 TABLE 25 NORTH AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77 TABLE 26 EUROPE: GENE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 78 TABLE 27 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 78 TABLE 28 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 78 7 GENE EDITING MARKET, BY TECHNOLOGY 79 7.1 INTRODUCTION 80 TABLE 29 GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 80 7.2 CRISPR 80 7.2.1 EASE OF USE TO BOOST DEMAND OVER OTHER TECHNOLOGIES 80 TABLE 30 GENE EDITING MARKET FOR CRISPR, BY REGION, 2021–2028 (USD MILLION) 81 TABLE 31 NORTH AMERICA: GENE EDITING MARKET FOR CRISPR, BY COUNTRY, 2021–2028 (USD MILLION) 81 TABLE 32 EUROPE: GENE EDITING MARKET FOR CRISPR, BY COUNTRY, 2021–2028 (USD MILLION) 81 TABLE 33 ASIA PACIFIC: GENE EDITING MARKET FOR CRISPR, BY COUNTRY, 2021–2028 (USD MILLION) 82 TABLE 34 LATIN AMERICA: GENE EDITING MARKET FOR CRISPR, BY COUNTRY, 2021–2028 (USD MILLION) 82 7.3 TALEN 82 7.3.1 ABILITY TO MAKE QUICK MODIFICATIONS TO DRIVE USAGE 82 TABLE 35 GENE EDITING MARKET FOR TALEN, BY REGION, 2021–2028 (USD MILLION) 83 TABLE 36 NORTH AMERICA: GENE EDITING MARKET FOR TALEN, BY COUNTRY, 2021–2028 (USD MILLION) 83 TABLE 37 EUROPE: GENE EDITING MARKET FOR TALEN, BY COUNTRY, 2021–2028 (USD MILLION) 83 TABLE 38 ASIA PACIFIC: GENE EDITING MARKET FOR TALEN, BY COUNTRY, 2021–2028 (USD MILLION) 84 TABLE 39 LATIN AMERICA: GENE EDITING MARKET FOR TALEN, BY COUNTRY, 2021–2028 (USD MILLION) 84 7.4 ZFN 84 7.4.1 UTILITY IN EUKARYOTE CELL STUDIES TO DRIVE MARKET GROWTH 84 TABLE 40 GENE EDITING MARKET FOR ZFN, BY REGION, 2021–2028 (USD MILLION) 85 TABLE 41 NORTH AMERICA: GENE EDITING MARKET FOR ZFN, BY COUNTRY, 2021–2028 (USD MILLION) 85 TABLE 42 EUROPE: GENE EDITING MARKET FOR ZFN, BY COUNTRY, 2021–2028 (USD MILLION) 85 TABLE 43 ASIA PACIFIC: GENE EDITING MARKET FOR ZFN, BY COUNTRY, 2021–2028 (USD MILLION) 86 TABLE 44 LATIN AMERICA: GENE EDITING MARKET FOR ZFN, BY COUNTRY, 2021–2028 (USD MILLION) 86 7.5 ANTISENSE 86 7.5.1 INCREASED APPLICATION IN ENGINEERING HUMAN CELLS FOR DISEASE STUDY TO DRIVE MARKET GROWTH 86 TABLE 45 GENE EDITING MARKET FOR ANTISENSE, BY REGION, 2021–2028 (USD MILLION) 87 TABLE 46 NORTH AMERICA: GENE EDITING MARKET FOR ANTISENSE, BY COUNTRY, 2021–2028 (USD MILLION) 87 TABLE 47 EUROPE: GENE EDITING MARKET FOR ANTISENSE, BY COUNTRY, 2021–2028 (USD MILLION) 87 TABLE 48 ASIA PACIFIC: GENE EDITING MARKET FOR ANTISENSE, BY COUNTRY, 2021–2028 (USD MILLION) 88 TABLE 49 LATIN AMERICA: GENE EDITING MARKET FOR ANTISENSE, BY COUNTRY, 2021–2028 (USD MILLION) 88 7.6 OTHER TECHNOLOGIES 88 TABLE 50 GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION) 89 TABLE 51 NORTH AMERICA: GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 89 TABLE 52 EUROPE: GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 89 TABLE 53 ASIA PACIFIC: GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 90 TABLE 54 LATIN AMERICA: GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 90 8 GENE EDITING MARKET, BY APPLICATION 91 8.1 INTRODUCTION 92 TABLE 55 GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 92 8.2 CELL LINE ENGINEERING 92 8.2.1 INCREASING RESEARCH APPLICATIONS TO PROMOTE MARKET GROWTH 92 TABLE 56 GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY REGION, 2021–2028 (USD MILLION) 93 TABLE 57 NORTH AMERICA: GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION) 93 TABLE 58 EUROPE: GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION) 93 TABLE 59 ASIA PACIFIC: GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION) 94 TABLE 60 LATIN AMERICA: GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION) 94 8.3 GENETIC ENGINEERING 94 8.3.1 GROWING USE OF ANIMAL SIMULATION MODELS IN RESEARCH AND INCREASING INTEREST IN GM CROPS TO DRIVE MARKET 94 TABLE 61 GENE EDITING MARKET FOR GENETIC ENGINEERING, BY REGION, 2021–2028 (USD MILLION) 95 TABLE 62 NORTH AMERICA: GENE EDITING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION) 95 TABLE 63 EUROPE: GENE EDITING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION) 96 TABLE 64 ASIA PACIFIC: GENE EDITING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION) 96 TABLE 65 LATIN AMERICA: GENE EDITING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION) 96 8.4 DRUG DISCOVERY & DEVELOPMENT 97 8.4.1 GROWING RESEARCH AND APPLICATIONS IN DRUG DISCOVERY & DEVELOPMENT TO BOOST GROWTH 97 TABLE 66 GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION) 97 TABLE 67 NORTH AMERICA: GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 98 TABLE 68 EUROPE: GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 98 TABLE 69 ASIA PACIFIC: GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 98 TABLE 70 LATIN AMERICA: GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 99 8.5 OTHER APPLICATIONS 99 TABLE 71 GENE EDITING MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 100 TABLE 72 NORTH AMERICA: GENE EDITING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 100 TABLE 73 EUROPE: GENE EDITING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 100 TABLE 74 ASIA PACIFIC: GENE EDITING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 101 TABLE 75 LATIN AMERICA: GENE EDITING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 101 9 GENE EDITING MARKET, BY END USER 102 9.1 INTRODUCTION 103 TABLE 76 GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 103 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 103 9.2.1 PHARMA & BIOTECH COMPANIES TO HOLD LARGEST MARKET SHARE 103 TABLE 77 GENE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 104 TABLE 78 NORTH AMERICA: GENE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 104 TABLE 79 EUROPE: GENE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 104 TABLE 80 ASIA PACIFIC: GENE EDITING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 105 TABLE 81 LATIN AMERICA: GENE EDITING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 105 9.3 ACADEMIC & RESEARCH INSTITUTES 105 9.3.1 TREND OF COLLABORATIVE RESEARCH TO SUPPORT MARKET GROWTH 105 TABLE 82 GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 106 TABLE 83 NORTH AMERICA: GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 106 TABLE 84 EUROPE: GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 107 TABLE 85 ASIA PACIFIC: GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 107 TABLE 86 LATIN AMERICA: GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 107 9.4 OTHER END USERS 108 TABLE 87 GENE EDITING MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 108 TABLE 88 NORTH AMERICA: GENE EDITING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 108 TABLE 89 EUROPE: GENE EDITING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 109 TABLE 90 ASIA PACIFIC: GENE EDITING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 109 TABLE 91 LATIN AMERICA: GENE EDITING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 109 10 GENE EDITING MARKET, BY REGION 110 10.1 INTRODUCTION 111 TABLE 92 GENE EDITING MARKET, BY REGION, 2021–2028 (USD MILLION) 111 10.2 NORTH AMERICA 111 10.2.1 NORTH AMERICA: RECESSION IMPACT 111 FIGURE 26 NORTH AMERICA: GENE EDITING MARKET SNAPSHOT 112 TABLE 93 NORTH AMERICA: GENE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113 TABLE 94 NORTH AMERICA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 113 TABLE 95 NORTH AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 113 TABLE 96 NORTH AMERICA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 114 TABLE 97 NORTH AMERICA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 114 10.2.2 US 114 10.2.2.1 Robust investment to drive market growth 114 TABLE 98 US: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 115 TABLE 99 US: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 115 TABLE 100 US: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 115 TABLE 101 US: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 116 10.2.3 CANADA 116 10.2.3.1 Availability of research funding to support growth 116 TABLE 102 CANADA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 116 TABLE 103 CANADA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 117 TABLE 104 CANADA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 117 TABLE 105 CANADA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 117 10.3 EUROPE 118 10.3.1 EUROPE: RECESSION IMPACT 118 TABLE 106 EUROPE: GENE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118 TABLE 107 EUROPE: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 119 TABLE 108 EUROPE: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 119 TABLE 109 EUROPE: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 119 TABLE 110 EUROPE: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 120 10.3.2 GERMANY 120 10.3.2.1 Strong academic base and rising awareness to boost market 120 TABLE 111 GERMANY: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 120 TABLE 112 GERMANY: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 121 TABLE 113 GERMANY: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 121 TABLE 114 GERMANY: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 121 10.3.3 UK 122 10.3.3.1 Government support to boost market growth 122 TABLE 115 UK: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 122 TABLE 116 UK: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 122 TABLE 117 UK: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 123 TABLE 118 UK: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 123 10.3.4 FRANCE 123 10.3.4.1 Government funding for genomics and rising research investments to propel market 123 TABLE 119 FRANCE: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 124 TABLE 120 FRANCE: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 124 TABLE 121 FRANCE: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 124 TABLE 122 FRANCE: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 125 10.3.5 ITALY 125 10.3.5.1 Increasing collaborations to drive genomic medicine research and favor market 125 TABLE 123 ITALY: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 125 TABLE 124 ITALY: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 126 TABLE 125 ITALY: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 126 TABLE 126 ITALY: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 126 10.3.6 SPAIN 127 10.3.6.1 Proactive research funding to boost market 127 TABLE 127 SPAIN: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 127 TABLE 128 SPAIN: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 127 TABLE 129 SPAIN: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 128 TABLE 130 SPAIN: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 128 10.3.7 REST OF EUROPE 128 TABLE 131 REST OF EUROPE: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 129 TABLE 132 REST OF EUROPE: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 129 TABLE 133 REST OF EUROPE: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 129 TABLE 134 REST OF EUROPE: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 130 10.4 ASIA PACIFIC 130 10.4.1 ASIA PACIFIC: RECESSION IMPACT 130 FIGURE 27 ASIA PACIFIC: GENE EDITING MARKET SNAPSHOT 131 TABLE 135 ASIA PACIFIC: GENE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132 TABLE 136 ASIA PACIFIC: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 132 TABLE 137 ASIA PACIFIC: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 132 TABLE 138 ASIA PACIFIC: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 133 TABLE 139 ASIA PACIFIC: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 133 10.4.2 CHINA 133 10.4.2.1 China to hold largest share of APAC market 133 TABLE 140 CHINA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 134 TABLE 141 CHINA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 134 TABLE 142 CHINA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 134 TABLE 143 CHINA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 135 10.4.3 JAPAN 135 10.4.3.1 Focus on cancer research to showcase favorable scenarios for gene editing market 135 TABLE 144 JAPAN: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 135 TABLE 145 JAPAN: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 136 TABLE 146 JAPAN: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 136 TABLE 147 JAPAN: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 136 10.4.4 INDIA 137 10.4.4.1 Growing startups and government support to boost growth potential 137 TABLE 148 INDIA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 137 TABLE 149 INDIA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 137 TABLE 150 INDIA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 138 TABLE 151 INDIA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 138 10.4.5 REST OF ASIA PACIFIC 138 TABLE 152 REST OF ASIA PACIFIC: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 139 TABLE 153 REST OF ASIA PACIFIC: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 139 TABLE 154 REST OF ASIA PACIFIC: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 139 TABLE 155 REST OF ASIA PACIFIC: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 140 10.5 LATIN AMERICA 140 10.5.1 LATIN AMERICA: RECESSION IMPACT 140 TABLE 156 LATIN AMERICA: GENE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141 TABLE 157 LATIN AMERICA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 141 TABLE 158 LATIN AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 141 TABLE 159 LATIN AMERICA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 142 TABLE 160 LATIN AMERICA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 142 10.5.2 BRAZIL 142 10.5.2.1 Brazil to dominate Latin American market 142 TABLE 161 BRAZIL: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 143 TABLE 162 BRAZIL: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 143 TABLE 163 BRAZIL: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 143 TABLE 164 BRAZIL: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 144 10.5.3 REST OF LATIN AMERICA 144 TABLE 165 REST OF LATIN AMERICA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 144 TABLE 166 REST OF LATIN AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 145 TABLE 167 REST OF LATIN AMERICA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 145 TABLE 168 REST OF LATIN AMERICA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 145 10.5.4 MIDDLE EAST & AFRICA 146 10.5.4.1 Increasing adoption of genetic testing to propel market 146 10.5.5 MIDDLE EAST & AFRICA: RECESSION IMPACT 146 TABLE 169 MIDDLE EAST & AFRICA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 147 TABLE 170 MIDDLE EAST & AFRICA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 147 TABLE 171 MIDDLE EAST & AFRICA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 147 TABLE 172 MIDDLE EAST & AFRICA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 148 11 COMPETITIVE LANDSCAPE 149 11.1 OVERVIEW 149 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 150 FIGURE 28 KEY PLAYER STRATEGIES, 2020–2023 150 11.3 MARKET SHARE ANALYSIS 151 TABLE 173 GENE EDITING MARKET: DEGREE OF COMPETITION 151 11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 152 FIGURE 30 REVENUE ANALYSIS OF TOP FOUR MARKET PLAYERS (2020–2022) 152 11.5 COMPANY EVALUATION QUADRANT, 2022 153 11.5.1 STARS 153 11.5.2 EMERGING LEADERS 153 11.5.3 PERVASIVE PLAYERS 153 11.5.4 EMERGING COMPANIES 153 FIGURE 31 GENE EDITING MARKET: COMPANY EVALUATION QUADRANT, 2022 154 11.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2022 155 11.6.1 PROGRESSIVE COMPANIES 155 11.6.2 STARTING BLOCKS 155 11.6.3 RESPONSIVE COMPANIES 155 11.6.4 DYNAMIC COMPANIES 155 FIGURE 32 GENE EDITING MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2022 156 11.7 COMPANY FOOTPRINT ANALYSIS 157 11.7.1 PRODUCT/SERVICE FOOTPRINT ANALYSIS 157 TABLE 174 PRODUCT/SERVICE FOOTPRINT ANALYSIS: GENE EDITING MARKET (2022) 157 11.7.2 GEOGRAPHIC FOOTPRINT ANALYSIS 158 TABLE 175 GEOGRAPHIC FOOTPRINT ANALYSIS: GENE EDITING MARKET (2022) 158 11.8 COMPETITIVE SCENARIO 159 12 COMPANY PROFILES 161 12.1 KEY COMPANIES 161 (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 12.1.1 THERMO FISHER SCIENTIFIC 161 TABLE 176 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW 161 FIGURE 33 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022) 162 12.1.2 MERCK KGAA 165 TABLE 177 MERCK KGAA: BUSINESS OVERVIEW 165 FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2022) 166 12.1.3 GENSCRIPT 169 TABLE 178 GENSCRIPT: BUSINESS OVERVIEW 169 FIGURE 35 GENSCRIPT: COMPANY SNAPSHOT (2022) 170 12.1.4 AGILENT TECHNOLOGIES 173 TABLE 179 AGILENT TECHNOLOGIES: BUSINESS OVERVIEW 173 FIGURE 36 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2022) 174 12.1.5 PERKINELMER 176 TABLE 180 PERKINELMER: BUSINESS OVERVIEW 176 FIGURE 37 PERKINELMER: COMPANY SNAPSHOT (2022) 177 12.1.6 LONZA 180 TABLE 181 LONZA: BUSINESS OVERVIEW 180 FIGURE 38 LONZA: COMPANY SNAPSHOT (2022) 181 12.1.7 TECAN LIFE SCIENCES 183 TABLE 182 TECAN LIFESCIENCES: BUSINESS OVERVIEW 183 FIGURE 39 TECAN LIFESCIENCES: COMPANY SNAPSHOT (2022) 184 12.1.8 SANGAMO THERAPEUTICS 186 TABLE 183 SANGAMO THERAPEUTICS: BUSINESS OVERVIEW 186 FIGURE 40 SANGAMO THERAPEUTICS: COMPANY SNAPSHOT (2022) 186 12.1.9 EDITAS MEDICINE 188 TABLE 184 EDITAS MEDICINE: BUSINESS OVERVIEW 188 FIGURE 41 EDITAS MEDICINE: COMPANY SNAPSHOT (2022) 188 12.1.10 CRISPR THERAPEUTICS AG 190 TABLE 185 CRISPR THERAPEUTICS AG: BUSINESS OVERVIEW 190 FIGURE 42 CRISPR THERAPEUTICS AG: COMPANY SNAPSHOT (2022) 190 12.1.11 PRECISION BIOSCIENCES 192 TABLE 186 PRECISION BIOSCIENCES: BUSINESS OVERVIEW 192 FIGURE 43 PRECISION BIOSCIENCES: COMPANY SNAPSHOT (2020) 192 12.1.12 CELLECTIS S.A. 194 TABLE 187 CELLECTIS: BUSINESS OVERVIEW 194 FIGURE 44 CELLECTIS: COMPANY SNAPSHOT (2022) 194 12.1.13 INTELLIA THERAPEUTICS 196 TABLE 188 INTELLIA THERAPEUTICS: BUSINESS OVERVIEW 196 FIGURE 45 INTELLIA THERAPEUTICS: COMPANY SNAPSHOT (2022) 196 12.1.14 BLUEBIRD BIO INC. 198 TABLE 189 BLUEBIRD BIO: BUSINESS OVERVIEW 198 FIGURE 46 BLUEBIRD BIO: COMPANY SNAPSHOT (2022) 198 12.1.15 REGENERON PHARMACEUTICALS INC. 200 TABLE 190 REGENERON PHARMACEUTICALS: BUSINESS OVERVIEW 200 FIGURE 47 REGENERON PHARMACEUTICALS: COMPANY SNAPSHOT (2022) 200 12.1.16 AMSBIO 202 TABLE 191 AMSBIO: BUSINESS OVERVIEW 202 12.1.17 CREATIVE BIOGENE 203 TABLE 192 CREATIVE BIOGENE: BUSINESS OVERVIEW 203 12.1.18 SYNTHEGO CORPORATION 204 TABLE 193 SYNTHEGO CORPORATION: BUSINESS OVERVIEW 204 12.1.19 BEAM THERAPEUTICS 206 TABLE 194 BEAM THERAPEUTICS: BUSINESS OVERVIEW 206 FIGURE 48 BEAM THERAPEUTICS: COMPANY SNAPSHOT (2022) 206 12.2 OTHER PLAYERS 207 12.2.1 CARIBOU BIOSCIENCES 207 12.2.2 ORIGENE TECHNOLOGIES 207 12.2.3 NEW ENGLAND BIOLABS 208 12.2.4 INSCRIPTA 208 12.2.5 MAMMOTH BIOSCIENCES 209 *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 13 APPENDIX 210 13.1 DISCUSSION GUIDE 210 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 213 13.3 CUSTOMIZATION OPTIONS 215 13.4 RELATED REPORTS 215 13.5 AUTHOR DETAILS 216
SummaryThe gene editing market is projected to grow from USD 5.3 billion in 2023 to USD 10.6 billion by 2028 at a CAGR of 15.0%. Rising government funding and number of genomics projects has emerged as a high impact driver for the market. In March 2022, the US National Institutes of Health (NIH) expanded its funding for gene editing research, allocating USD 89 million for additional projects. Similarly, the European Union launched the Horizon 2020 program, providing substantial financial resources to promote genomics research and gene editing projects. Moreover, several countries, including China, Japan, and South Korea, have established national genomics programs and dedicated funding to drive advancements in gene editing technologies. Table of Contents1 INTRODUCTION 301.1 STUDY OBJECTIVES 30 1.2 MARKET DEFINITION 30 1.2.1 INCLUSIONS & EXCLUSIONS 30 1.3 MARKET SCOPE 31 1.3.1 MARKETS COVERED 31 1.4 YEARS CONSIDERED 31 1.5 CURRENCY CONSIDERED 32 1.6 LIMITATIONS 32 1.7 STAKEHOLDERS 32 1.8 SUMMARY OF CHANGES 33 2 RESEARCH METHODOLOGY 34 2.1 RESEARCH DATA 34 FIGURE 1 RESEARCH DESIGN 34 2.1.1 SECONDARY DATA 35 2.1.2 PRIMARY DATA 35 FIGURE 2 BREAKDOWN OF PRIMARIES: GENE EDITING MARKET 36 2.2 MARKET ESTIMATION METHODOLOGY 37 FIGURE 3 GENE EDITING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022 37 FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022 38 2.2.1 INSIGHTS FROM PRIMARY EXPERTS 39 FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 39 2.3 MARKET GROWTH RATE PROJECTIONS 40 FIGURE 6 GENE EDITING MARKET (SUPPLY-SIDE): CAGR PROJECTIONS 41 FIGURE 7 GENE EDITING MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS 41 2.4 DATA TRIANGULATION 42 FIGURE 8 DATA TRIANGULATION METHODOLOGY 42 2.5 RESEARCH ASSUMPTIONS 43 2.6 RISK ANALYSIS 43 2.7 RECESSION IMPACT ANALYSIS 43 TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 44 TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 44 TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 44 3 EXECUTIVE SUMMARY 45 FIGURE 9 GENE EDITING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 45 FIGURE 10 GENE EDITING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 46 FIGURE 11 GENE EDITING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 46 FIGURE 12 GENE EDITING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 47 FIGURE 13 GEOGRAPHICAL SNAPSHOT: GENE EDITING MARKET, 2022 48 4 PREMIUM INSIGHTS 49 4.1 GENE EDITING MARKET OVERVIEW 49 FIGURE 14 GROWING INVESTMENTS IN GENOMICS RESEARCH TO DRIVE MARKET GROWTH 49 4.2 NORTH AMERICA: GENE EDITING MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022) 50 FIGURE 15 REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 50 4.3 NORTH AMERICA GENE EDITING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 50 FIGURE 16 CELL LINE ENGINEERING TO DOMINATE NORTH AMERICAN MARKET 50 5 MARKET OVERVIEW 51 5.1 INTRODUCTION 51 5.2 MARKET DYNAMICS 51 FIGURE 17 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51 TABLE 4 GENOME EDITING MARKET: IMPACT ANALYSIS 52 5.2.1 DRIVERS 52 5.2.1.1 Rising government funding and number of genomics projects 52 5.2.1.2 Growing applications of genomics 53 5.2.1.3 Introduction of CRISPR-Cas9 54 5.2.2 RESTRAINTS 54 5.2.2.1 Off-target effects of CRISPR technology 54 5.2.3 OPPORTUNITIES 55 5.2.3.1 Extensive use of genome editing in personalized medicine 55 5.2.3.2 Expanding pipeline for gene therapy 55 5.2.4 CHALLENGES 56 5.2.4.1 High equipment costs 56 5.3 TECHNOLOGY ANALYSIS 56 5.4 SUPPLY AND VALUE CHAIN ANALYSIS 58 5.4.1 GENE EDITING MARKET: SUPPLY CHAIN ANALYSIS 58 FIGURE 18 GENE EDITING MARKET: SUPPLY CHAIN ANALYSIS 58 5.4.2 VALUE CHAIN ANALYSIS 59 FIGURE 19 GENE EDITING MARKET: VALUE CHAIN ANALYSIS 59 5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 60 FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 60 5.6 PRICING ANALYSIS 61 TABLE 5 AVERAGE SELLING PRICES, BY PRODUCT (KEY PLAYER OFFERINGS) 61 5.7 REGULATORY ANALYSIS 62 5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62 TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62 TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63 TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64 TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65 TABLE 10 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66 5.8 ECOSYSTEM ANALYSIS 66 FIGURE 21 GENE EDITING MARKET: ECOSYSTEM ANALYSIS 66 5.9 PORTER’S FIVE FORCES ANALYSIS 67 TABLE 11 GENE EDITING MARKET: PORTER’S FIVE FORCES ANALYSIS 67 5.9.1 THREAT OF NEW ENTRANTS 67 5.9.2 THREAT OF SUBSTITUTES 67 5.9.3 BARGAINING POWER OF BUYERS 67 5.9.4 BARGAINING POWER OF SUPPLIERS 68 5.9.5 INTENSITY OF COMPETITIVE RIVALRY 68 5.10 KEY CONFERENCES AND EVENTS IN 2023 68 TABLE 12 GENE EDITING MARKET: CONFERENCES AND EVENTS (2023) 68 5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 69 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 69 FIGURE 22 GENE EDITING MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 69 5.11.2 GENE EDITING MARKET: BUYING CRITERIA 69 FIGURE 23 KEY BUYING CRITERIA FOR GENE EDITING 69 5.12 PATENT ANALYSIS 70 FIGURE 24 PATENTS GRANTED, JANUARY 2011–JUNE 2023 70 FIGURE 25 TOP PATENT APPLICANTS, JANUARY 2011–JUNE 2023 70 6 GENE EDITING MARKET, BY PRODUCT & SERVICE 71 6.1 INTRODUCTION 72 TABLE 13 GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 72 6.2 REAGENTS & CONSUMABLES 72 6.2.1 REAGENTS & CONSUMABLES TO HOLD LARGEST MARKET SHARE 72 TABLE 14 GENE EDITING REAGENTS & CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 73 TABLE 15 NORTH AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 73 TABLE 16 EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 73 TABLE 17 ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 74 TABLE 18 LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 74 6.3 SOFTWARE & SYSTEMS 74 6.3.1 INCREASING APPLICATIONS OF GENOME EDITING/SEQUENCING TO BOOST DEMAND FOR SYSTEMS AND SOFTWARE 74 TABLE 19 GENE EDITING SOFTWARE & SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 75 TABLE 20 NORTH AMERICA: GENE EDITING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 75 TABLE 21 EUROPE: GENE EDITING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76 TABLE 22 ASIA PACIFIC: GENE EDITING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76 TABLE 23 LATIN AMERICA: GENE EDITING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76 6.4 SERVICES 77 6.4.1 RISING DEMAND FOR SERVICES TO SUPPORT GROWTH 77 TABLE 24 GENE EDITING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 77 TABLE 25 NORTH AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77 TABLE 26 EUROPE: GENE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 78 TABLE 27 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 78 TABLE 28 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 78 7 GENE EDITING MARKET, BY TECHNOLOGY 79 7.1 INTRODUCTION 80 TABLE 29 GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 80 7.2 CRISPR 80 7.2.1 EASE OF USE TO BOOST DEMAND OVER OTHER TECHNOLOGIES 80 TABLE 30 GENE EDITING MARKET FOR CRISPR, BY REGION, 2021–2028 (USD MILLION) 81 TABLE 31 NORTH AMERICA: GENE EDITING MARKET FOR CRISPR, BY COUNTRY, 2021–2028 (USD MILLION) 81 TABLE 32 EUROPE: GENE EDITING MARKET FOR CRISPR, BY COUNTRY, 2021–2028 (USD MILLION) 81 TABLE 33 ASIA PACIFIC: GENE EDITING MARKET FOR CRISPR, BY COUNTRY, 2021–2028 (USD MILLION) 82 TABLE 34 LATIN AMERICA: GENE EDITING MARKET FOR CRISPR, BY COUNTRY, 2021–2028 (USD MILLION) 82 7.3 TALEN 82 7.3.1 ABILITY TO MAKE QUICK MODIFICATIONS TO DRIVE USAGE 82 TABLE 35 GENE EDITING MARKET FOR TALEN, BY REGION, 2021–2028 (USD MILLION) 83 TABLE 36 NORTH AMERICA: GENE EDITING MARKET FOR TALEN, BY COUNTRY, 2021–2028 (USD MILLION) 83 TABLE 37 EUROPE: GENE EDITING MARKET FOR TALEN, BY COUNTRY, 2021–2028 (USD MILLION) 83 TABLE 38 ASIA PACIFIC: GENE EDITING MARKET FOR TALEN, BY COUNTRY, 2021–2028 (USD MILLION) 84 TABLE 39 LATIN AMERICA: GENE EDITING MARKET FOR TALEN, BY COUNTRY, 2021–2028 (USD MILLION) 84 7.4 ZFN 84 7.4.1 UTILITY IN EUKARYOTE CELL STUDIES TO DRIVE MARKET GROWTH 84 TABLE 40 GENE EDITING MARKET FOR ZFN, BY REGION, 2021–2028 (USD MILLION) 85 TABLE 41 NORTH AMERICA: GENE EDITING MARKET FOR ZFN, BY COUNTRY, 2021–2028 (USD MILLION) 85 TABLE 42 EUROPE: GENE EDITING MARKET FOR ZFN, BY COUNTRY, 2021–2028 (USD MILLION) 85 TABLE 43 ASIA PACIFIC: GENE EDITING MARKET FOR ZFN, BY COUNTRY, 2021–2028 (USD MILLION) 86 TABLE 44 LATIN AMERICA: GENE EDITING MARKET FOR ZFN, BY COUNTRY, 2021–2028 (USD MILLION) 86 7.5 ANTISENSE 86 7.5.1 INCREASED APPLICATION IN ENGINEERING HUMAN CELLS FOR DISEASE STUDY TO DRIVE MARKET GROWTH 86 TABLE 45 GENE EDITING MARKET FOR ANTISENSE, BY REGION, 2021–2028 (USD MILLION) 87 TABLE 46 NORTH AMERICA: GENE EDITING MARKET FOR ANTISENSE, BY COUNTRY, 2021–2028 (USD MILLION) 87 TABLE 47 EUROPE: GENE EDITING MARKET FOR ANTISENSE, BY COUNTRY, 2021–2028 (USD MILLION) 87 TABLE 48 ASIA PACIFIC: GENE EDITING MARKET FOR ANTISENSE, BY COUNTRY, 2021–2028 (USD MILLION) 88 TABLE 49 LATIN AMERICA: GENE EDITING MARKET FOR ANTISENSE, BY COUNTRY, 2021–2028 (USD MILLION) 88 7.6 OTHER TECHNOLOGIES 88 TABLE 50 GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION) 89 TABLE 51 NORTH AMERICA: GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 89 TABLE 52 EUROPE: GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 89 TABLE 53 ASIA PACIFIC: GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 90 TABLE 54 LATIN AMERICA: GENE EDITING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 90 8 GENE EDITING MARKET, BY APPLICATION 91 8.1 INTRODUCTION 92 TABLE 55 GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 92 8.2 CELL LINE ENGINEERING 92 8.2.1 INCREASING RESEARCH APPLICATIONS TO PROMOTE MARKET GROWTH 92 TABLE 56 GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY REGION, 2021–2028 (USD MILLION) 93 TABLE 57 NORTH AMERICA: GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION) 93 TABLE 58 EUROPE: GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION) 93 TABLE 59 ASIA PACIFIC: GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION) 94 TABLE 60 LATIN AMERICA: GENE EDITING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION) 94 8.3 GENETIC ENGINEERING 94 8.3.1 GROWING USE OF ANIMAL SIMULATION MODELS IN RESEARCH AND INCREASING INTEREST IN GM CROPS TO DRIVE MARKET 94 TABLE 61 GENE EDITING MARKET FOR GENETIC ENGINEERING, BY REGION, 2021–2028 (USD MILLION) 95 TABLE 62 NORTH AMERICA: GENE EDITING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION) 95 TABLE 63 EUROPE: GENE EDITING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION) 96 TABLE 64 ASIA PACIFIC: GENE EDITING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION) 96 TABLE 65 LATIN AMERICA: GENE EDITING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2021–2028 (USD MILLION) 96 8.4 DRUG DISCOVERY & DEVELOPMENT 97 8.4.1 GROWING RESEARCH AND APPLICATIONS IN DRUG DISCOVERY & DEVELOPMENT TO BOOST GROWTH 97 TABLE 66 GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION) 97 TABLE 67 NORTH AMERICA: GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 98 TABLE 68 EUROPE: GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 98 TABLE 69 ASIA PACIFIC: GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 98 TABLE 70 LATIN AMERICA: GENE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 99 8.5 OTHER APPLICATIONS 99 TABLE 71 GENE EDITING MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 100 TABLE 72 NORTH AMERICA: GENE EDITING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 100 TABLE 73 EUROPE: GENE EDITING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 100 TABLE 74 ASIA PACIFIC: GENE EDITING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 101 TABLE 75 LATIN AMERICA: GENE EDITING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 101 9 GENE EDITING MARKET, BY END USER 102 9.1 INTRODUCTION 103 TABLE 76 GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 103 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 103 9.2.1 PHARMA & BIOTECH COMPANIES TO HOLD LARGEST MARKET SHARE 103 TABLE 77 GENE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 104 TABLE 78 NORTH AMERICA: GENE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 104 TABLE 79 EUROPE: GENE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 104 TABLE 80 ASIA PACIFIC: GENE EDITING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 105 TABLE 81 LATIN AMERICA: GENE EDITING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 105 9.3 ACADEMIC & RESEARCH INSTITUTES 105 9.3.1 TREND OF COLLABORATIVE RESEARCH TO SUPPORT MARKET GROWTH 105 TABLE 82 GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 106 TABLE 83 NORTH AMERICA: GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 106 TABLE 84 EUROPE: GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 107 TABLE 85 ASIA PACIFIC: GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 107 TABLE 86 LATIN AMERICA: GENE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 107 9.4 OTHER END USERS 108 TABLE 87 GENE EDITING MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 108 TABLE 88 NORTH AMERICA: GENE EDITING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 108 TABLE 89 EUROPE: GENE EDITING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 109 TABLE 90 ASIA PACIFIC: GENE EDITING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 109 TABLE 91 LATIN AMERICA: GENE EDITING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 109 10 GENE EDITING MARKET, BY REGION 110 10.1 INTRODUCTION 111 TABLE 92 GENE EDITING MARKET, BY REGION, 2021–2028 (USD MILLION) 111 10.2 NORTH AMERICA 111 10.2.1 NORTH AMERICA: RECESSION IMPACT 111 FIGURE 26 NORTH AMERICA: GENE EDITING MARKET SNAPSHOT 112 TABLE 93 NORTH AMERICA: GENE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113 TABLE 94 NORTH AMERICA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 113 TABLE 95 NORTH AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 113 TABLE 96 NORTH AMERICA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 114 TABLE 97 NORTH AMERICA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 114 10.2.2 US 114 10.2.2.1 Robust investment to drive market growth 114 TABLE 98 US: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 115 TABLE 99 US: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 115 TABLE 100 US: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 115 TABLE 101 US: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 116 10.2.3 CANADA 116 10.2.3.1 Availability of research funding to support growth 116 TABLE 102 CANADA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 116 TABLE 103 CANADA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 117 TABLE 104 CANADA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 117 TABLE 105 CANADA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 117 10.3 EUROPE 118 10.3.1 EUROPE: RECESSION IMPACT 118 TABLE 106 EUROPE: GENE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118 TABLE 107 EUROPE: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 119 TABLE 108 EUROPE: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 119 TABLE 109 EUROPE: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 119 TABLE 110 EUROPE: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 120 10.3.2 GERMANY 120 10.3.2.1 Strong academic base and rising awareness to boost market 120 TABLE 111 GERMANY: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 120 TABLE 112 GERMANY: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 121 TABLE 113 GERMANY: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 121 TABLE 114 GERMANY: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 121 10.3.3 UK 122 10.3.3.1 Government support to boost market growth 122 TABLE 115 UK: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 122 TABLE 116 UK: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 122 TABLE 117 UK: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 123 TABLE 118 UK: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 123 10.3.4 FRANCE 123 10.3.4.1 Government funding for genomics and rising research investments to propel market 123 TABLE 119 FRANCE: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 124 TABLE 120 FRANCE: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 124 TABLE 121 FRANCE: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 124 TABLE 122 FRANCE: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 125 10.3.5 ITALY 125 10.3.5.1 Increasing collaborations to drive genomic medicine research and favor market 125 TABLE 123 ITALY: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 125 TABLE 124 ITALY: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 126 TABLE 125 ITALY: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 126 TABLE 126 ITALY: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 126 10.3.6 SPAIN 127 10.3.6.1 Proactive research funding to boost market 127 TABLE 127 SPAIN: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 127 TABLE 128 SPAIN: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 127 TABLE 129 SPAIN: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 128 TABLE 130 SPAIN: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 128 10.3.7 REST OF EUROPE 128 TABLE 131 REST OF EUROPE: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 129 TABLE 132 REST OF EUROPE: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 129 TABLE 133 REST OF EUROPE: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 129 TABLE 134 REST OF EUROPE: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 130 10.4 ASIA PACIFIC 130 10.4.1 ASIA PACIFIC: RECESSION IMPACT 130 FIGURE 27 ASIA PACIFIC: GENE EDITING MARKET SNAPSHOT 131 TABLE 135 ASIA PACIFIC: GENE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132 TABLE 136 ASIA PACIFIC: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 132 TABLE 137 ASIA PACIFIC: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 132 TABLE 138 ASIA PACIFIC: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 133 TABLE 139 ASIA PACIFIC: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 133 10.4.2 CHINA 133 10.4.2.1 China to hold largest share of APAC market 133 TABLE 140 CHINA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 134 TABLE 141 CHINA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 134 TABLE 142 CHINA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 134 TABLE 143 CHINA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 135 10.4.3 JAPAN 135 10.4.3.1 Focus on cancer research to showcase favorable scenarios for gene editing market 135 TABLE 144 JAPAN: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 135 TABLE 145 JAPAN: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 136 TABLE 146 JAPAN: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 136 TABLE 147 JAPAN: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 136 10.4.4 INDIA 137 10.4.4.1 Growing startups and government support to boost growth potential 137 TABLE 148 INDIA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 137 TABLE 149 INDIA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 137 TABLE 150 INDIA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 138 TABLE 151 INDIA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 138 10.4.5 REST OF ASIA PACIFIC 138 TABLE 152 REST OF ASIA PACIFIC: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 139 TABLE 153 REST OF ASIA PACIFIC: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 139 TABLE 154 REST OF ASIA PACIFIC: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 139 TABLE 155 REST OF ASIA PACIFIC: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 140 10.5 LATIN AMERICA 140 10.5.1 LATIN AMERICA: RECESSION IMPACT 140 TABLE 156 LATIN AMERICA: GENE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141 TABLE 157 LATIN AMERICA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 141 TABLE 158 LATIN AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 141 TABLE 159 LATIN AMERICA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 142 TABLE 160 LATIN AMERICA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 142 10.5.2 BRAZIL 142 10.5.2.1 Brazil to dominate Latin American market 142 TABLE 161 BRAZIL: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 143 TABLE 162 BRAZIL: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 143 TABLE 163 BRAZIL: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 143 TABLE 164 BRAZIL: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 144 10.5.3 REST OF LATIN AMERICA 144 TABLE 165 REST OF LATIN AMERICA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 144 TABLE 166 REST OF LATIN AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 145 TABLE 167 REST OF LATIN AMERICA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 145 TABLE 168 REST OF LATIN AMERICA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 145 10.5.4 MIDDLE EAST & AFRICA 146 10.5.4.1 Increasing adoption of genetic testing to propel market 146 10.5.5 MIDDLE EAST & AFRICA: RECESSION IMPACT 146 TABLE 169 MIDDLE EAST & AFRICA: GENE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 147 TABLE 170 MIDDLE EAST & AFRICA: GENE EDITING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 147 TABLE 171 MIDDLE EAST & AFRICA: GENE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 147 TABLE 172 MIDDLE EAST & AFRICA: GENE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION) 148 11 COMPETITIVE LANDSCAPE 149 11.1 OVERVIEW 149 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 150 FIGURE 28 KEY PLAYER STRATEGIES, 2020–2023 150 11.3 MARKET SHARE ANALYSIS 151 TABLE 173 GENE EDITING MARKET: DEGREE OF COMPETITION 151 11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 152 FIGURE 30 REVENUE ANALYSIS OF TOP FOUR MARKET PLAYERS (2020–2022) 152 11.5 COMPANY EVALUATION QUADRANT, 2022 153 11.5.1 STARS 153 11.5.2 EMERGING LEADERS 153 11.5.3 PERVASIVE PLAYERS 153 11.5.4 EMERGING COMPANIES 153 FIGURE 31 GENE EDITING MARKET: COMPANY EVALUATION QUADRANT, 2022 154 11.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2022 155 11.6.1 PROGRESSIVE COMPANIES 155 11.6.2 STARTING BLOCKS 155 11.6.3 RESPONSIVE COMPANIES 155 11.6.4 DYNAMIC COMPANIES 155 FIGURE 32 GENE EDITING MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2022 156 11.7 COMPANY FOOTPRINT ANALYSIS 157 11.7.1 PRODUCT/SERVICE FOOTPRINT ANALYSIS 157 TABLE 174 PRODUCT/SERVICE FOOTPRINT ANALYSIS: GENE EDITING MARKET (2022) 157 11.7.2 GEOGRAPHIC FOOTPRINT ANALYSIS 158 TABLE 175 GEOGRAPHIC FOOTPRINT ANALYSIS: GENE EDITING MARKET (2022) 158 11.8 COMPETITIVE SCENARIO 159 12 COMPANY PROFILES 161 12.1 KEY COMPANIES 161 (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 12.1.1 THERMO FISHER SCIENTIFIC 161 TABLE 176 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW 161 FIGURE 33 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022) 162 12.1.2 MERCK KGAA 165 TABLE 177 MERCK KGAA: BUSINESS OVERVIEW 165 FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2022) 166 12.1.3 GENSCRIPT 169 TABLE 178 GENSCRIPT: BUSINESS OVERVIEW 169 FIGURE 35 GENSCRIPT: COMPANY SNAPSHOT (2022) 170 12.1.4 AGILENT TECHNOLOGIES 173 TABLE 179 AGILENT TECHNOLOGIES: BUSINESS OVERVIEW 173 FIGURE 36 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2022) 174 12.1.5 PERKINELMER 176 TABLE 180 PERKINELMER: BUSINESS OVERVIEW 176 FIGURE 37 PERKINELMER: COMPANY SNAPSHOT (2022) 177 12.1.6 LONZA 180 TABLE 181 LONZA: BUSINESS OVERVIEW 180 FIGURE 38 LONZA: COMPANY SNAPSHOT (2022) 181 12.1.7 TECAN LIFE SCIENCES 183 TABLE 182 TECAN LIFESCIENCES: BUSINESS OVERVIEW 183 FIGURE 39 TECAN LIFESCIENCES: COMPANY SNAPSHOT (2022) 184 12.1.8 SANGAMO THERAPEUTICS 186 TABLE 183 SANGAMO THERAPEUTICS: BUSINESS OVERVIEW 186 FIGURE 40 SANGAMO THERAPEUTICS: COMPANY SNAPSHOT (2022) 186 12.1.9 EDITAS MEDICINE 188 TABLE 184 EDITAS MEDICINE: BUSINESS OVERVIEW 188 FIGURE 41 EDITAS MEDICINE: COMPANY SNAPSHOT (2022) 188 12.1.10 CRISPR THERAPEUTICS AG 190 TABLE 185 CRISPR THERAPEUTICS AG: BUSINESS OVERVIEW 190 FIGURE 42 CRISPR THERAPEUTICS AG: COMPANY SNAPSHOT (2022) 190 12.1.11 PRECISION BIOSCIENCES 192 TABLE 186 PRECISION BIOSCIENCES: BUSINESS OVERVIEW 192 FIGURE 43 PRECISION BIOSCIENCES: COMPANY SNAPSHOT (2020) 192 12.1.12 CELLECTIS S.A. 194 TABLE 187 CELLECTIS: BUSINESS OVERVIEW 194 FIGURE 44 CELLECTIS: COMPANY SNAPSHOT (2022) 194 12.1.13 INTELLIA THERAPEUTICS 196 TABLE 188 INTELLIA THERAPEUTICS: BUSINESS OVERVIEW 196 FIGURE 45 INTELLIA THERAPEUTICS: COMPANY SNAPSHOT (2022) 196 12.1.14 BLUEBIRD BIO INC. 198 TABLE 189 BLUEBIRD BIO: BUSINESS OVERVIEW 198 FIGURE 46 BLUEBIRD BIO: COMPANY SNAPSHOT (2022) 198 12.1.15 REGENERON PHARMACEUTICALS INC. 200 TABLE 190 REGENERON PHARMACEUTICALS: BUSINESS OVERVIEW 200 FIGURE 47 REGENERON PHARMACEUTICALS: COMPANY SNAPSHOT (2022) 200 12.1.16 AMSBIO 202 TABLE 191 AMSBIO: BUSINESS OVERVIEW 202 12.1.17 CREATIVE BIOGENE 203 TABLE 192 CREATIVE BIOGENE: BUSINESS OVERVIEW 203 12.1.18 SYNTHEGO CORPORATION 204 TABLE 193 SYNTHEGO CORPORATION: BUSINESS OVERVIEW 204 12.1.19 BEAM THERAPEUTICS 206 TABLE 194 BEAM THERAPEUTICS: BUSINESS OVERVIEW 206 FIGURE 48 BEAM THERAPEUTICS: COMPANY SNAPSHOT (2022) 206 12.2 OTHER PLAYERS 207 12.2.1 CARIBOU BIOSCIENCES 207 12.2.2 ORIGENE TECHNOLOGIES 207 12.2.3 NEW ENGLAND BIOLABS 208 12.2.4 INSCRIPTA 208 12.2.5 MAMMOTH BIOSCIENCES 209 *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 13 APPENDIX 210 13.1 DISCUSSION GUIDE 210 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 213 13.3 CUSTOMIZATION OPTIONS 215 13.4 RELATED REPORTS 215 13.5 AUTHOR DETAILS 216
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(バイオ薬物)の最新刊レポート
MarketsandMarkets社のBiotechnology分野での最新刊レポート
本レポートと同じKEY WORD(drug)の最新刊レポート
よくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/22 10:26 155.52 円 163.34 円 198.56 円 |